Clinical trial
PIoglitazone for PrEvention of Restenosis in Diabetic Patients
NCT00376870 · University of Rome Tor Vergata, Other · Unknown status
Key facts
| NCT number | NCT00376870 |
|---|---|
| Title | PIoglitazone for PrEvention of Restenosis in Diabetic Patients |
| Official title | Prevention of Coronary Artery in STENT Restenosis With the Combined Use of Pioglitazone and Sirolimus-Eluting Coronary Stent |
| Lead sponsor | University of Rome Tor Vergata, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Atherosclerosis, Coronary Restenosis, Diabetes |
| Intervention type | Drug |
| Interventions | Pioglitazone, Placebo |
| Enrollment | 160 |
| Start date | Jul 1, 2008 |
| Primary completion | Dec 1, 2010 |
| Completion | Apr 1, 2011 |
| First posted | Sep 15, 2006 |
| Last update posted | Aug 1, 2008 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: